Who Owns Medicube?
Medicube is owned by APR Corp, a South Korean beauty-technology company founded in 2014 by Byunghoon (Victor) Kim and listed on the Korea Exchange since February 2024. It went from cheap pore pads to a billion-dollar business in under a decade. Here is the sourced version of how, and what that means when you are deciding what to buy.
Written by the Medicube Reviews editorial team. We are independent and not affiliated with Medicube or APR Corp. Every figure below is linked to its source at the foot of the page, and the numbers come from company filings and major outlets rather than from Medicube's own marketing.
Who owns Medicube?
Medicube is a brand of APR Corp, a South Korean beauty-and-technology company founded in 2014 by Byunghoon (Victor) Kim, which started with the brand Aprilskin. Medicube itself launched in July 2016, positioned around a simple idea: bring the kind of results you would associate with a dermatology clinic into an affordable at-home routine.
From pore pads to a public company
Medicube's early traction came from inexpensive, high-repeat products, most famously the Zero Pore pads, which built a large, loyal customer base. APR then layered a much higher-margin product line on top: the Age-R at-home beauty devices. That "cheap consumables to build the audience, premium devices to build the margin" model is central to understanding the brand, and it is why the range runs all the way from everyday pads and cleansers to devices costing several hundred. Our cheapest-first list shows where the entry point actually sits, with the date we read each price.
In February 2024, APR Corp listed on the Korea Exchange. The IPO priced above its indicated range and raised about KRW 94.8 billion, roughly US $71 million. The stock jumped 27% on debut, valuing the company at around US $1.8 billion, a striking number for a brand still best known to many shoppers for viral toner pads.
How big is it now, and where does the money come from?
APR has grown fast. Its 2025 revenue was KRW 1.53 trillion (about US $1.05 billion), up 111% on the year at a 24% operating margin, and about 80% of it was earned outside Korea.
The split is worth knowing, because it is the opposite of what the brand's device-heavy marketing suggests. APR reports the beauty devices at KRW 407.0 billion of that KRW 1.53 trillion, which works out at about 27% of the company. Skincare alone passed KRW 1 trillion for the first time. So the devices are the high-margin part of the business, not the big part. Cumulative Age-R sales did pass six million units in January 2026, up from roughly fifty thousand in the first year, so the growth is real; it just sits on a much larger skincare base.
The 27% is our own arithmetic on the two figures APR published, not a percentage APR itself reports. We have not seen a published cosmetics percentage, only the "over KRW 1 trillion" line, so we do not put a number on it.
What the names actually mean
This comes up often enough to answer plainly, and one of the three answers is that there is no answer.
- APR: Advance People’s Real Life
- The parent company’s own explanation of its initials.(apr-in.com)
- Age-R: Age Reverse
- The device line’s name, from the company’s stated aim of treating ageing as an engineering problem.(WIPO)
- Medicube: No published explanation
- The company has not published an official account of the name. It is widely read as a compound of "medical" and "cube", and the brand positions itself as clinic-style care at home, but we are not going to state a derivation the owner has never confirmed.
Why this matters when you are buying
Two takeaways for shoppers. First, the brand's scale and public-company status mean the products are real, widely used and consistently stocked, not a fly-by-night dupe operation. Second, the business model explains the pricing: the cheap pads and serums are genuinely good value and act as an entry point, while the devices carry the premium. That is not a criticism, just useful context. Our job is to tell you honestly which Medicube products are worth it and which are not, whatever the marketing says. Start with our product finder or the best-of guides.
A dermatologist's take
We have not tested these products ourselves, so here is someone who works with skin for a living looking at the brand from the outside. It is not our video and not a Medicube one.
"Dermatologist Reviews Medicube: The Truth About the Viral K-Beauty Brand" by Dr. Jenny Liu. Not our video and not a Medicube one. Loaded from YouTube when you press play.
Video by Dr. Jenny Liu on YouTube. We have no connection to the channel and it is not sponsored by us.
Frequently asked questions
Who owns Medicube?
Medicube is owned by APR Corp (also written APR Co., Ltd.), a South Korean beauty and technology company founded in 2014. APR is publicly listed on the Korea Exchange, where it floated in February 2024.
When was Medicube founded?
The Medicube brand launched in July 2016 under APR Corp, with the stated aim of bringing dermatology-clinic style results into an at-home routine.
Is Medicube a big company?
Yes. Its parent APR Corp reported KRW 1.53 trillion (about US $1.05 billion) in 2025 revenue, up 111% on the year, with about 80% of that earned outside Korea.
How much is Medicube worth?
Its parent APR Corp was valued at roughly US $1.8 billion when it listed in February 2024, and reported KRW 1.53 trillion (about US $1.05 billion) in revenue for 2025. Medicube is the largest brand within that group rather than a separately valued company.
Who founded Medicube?
Byunghoon (Victor) Kim founded the parent company APR Corp in Seoul in 2014, starting with the brand Aprilskin. Medicube launched under APR in July 2016.
What does the name Medicube mean?
The company has not published an official explanation. It is widely read as a compound of "medical" and "cube". Two related names are documented: APR stands for Advance People’s Real Life, and the Age-R device line is named for Age Reverse.
Is Medicube a Korean brand?
Yes. Medicube is a South Korean brand, owned by APR Corp, which was founded in Seoul in 2014 and is listed on the Korea Exchange. The products in our range are Korean-made K-beauty, sold internationally; about 80% of APR's 2025 revenue was earned outside Korea.
How long has Medicube been around?
The Medicube brand launched in July 2016, so it is about ten years old. Its parent company, APR Corp, is slightly older, founded in 2014. It is not a new label, but it is much younger than the legacy Korean houses.
What is Medicube's valuation or net worth?
There is no separate valuation for Medicube itself, because it is a brand inside APR Corp rather than its own company. What is on record is APR: it was worth roughly US $1.8 billion when it listed in February 2024, and it reported KRW 1.53 trillion (about US $1.05 billion) of revenue in 2025. A listed company's market value moves daily, so treat the 2024 figure as the listing-day number rather than today's.
Is Medicube a doctor or dermatologist brand?
Not as far as we can verify. The name and the "clinic-style care at home" positioning suggest a medical angle, but APR does not publish a claim that Medicube is founded or formulated by dermatologists, and we did not find one. Its founder, Byunghoon (Victor) Kim, is not described as a physician in the company's own materials. Treat the clinical feel as positioning, not credentials.
Does Medicube mostly sell devices or skincare?
Skincare, by revenue. APR reports the beauty devices at KRW 407.0 billion of its KRW 1.53 trillion 2025 revenue, which works out at about 27% by our own arithmetic, and says cosmetics alone passed KRW 1 trillion for the first time. APR does not publish a percentage split, so we do not put a figure on the skincare side. Devices are the higher-margin part of the story rather than the larger part.
Where these figures come from
Each number on this page traces to one of these. Company announcements are used for company figures, and independent outlets for market and valuation reporting.